Tracking Health and Wellness Applications of Brain Science

cognitive-behavioral-therapy

Debate: How and when will the telemedicine surge reach mental healthcare?

by Leave a Comment

Covid-19 Pan­dem­ic Dri­ves Patients—and Deal Makers—to Telemed­i­cine (The Wall Street Jour­nal):

The coro­n­avirus pan­dem­ic has put the once-niche cat­e­go­ry of telemed­i­cine in the spot­light and is now dri­ving a flur­ry of deal activ­i­ty involv­ing vir­tu­al health-care providers … Patients have embraced vir­tu­al care as a way to stay in touch with doc­tors for urgent care or chron­ic care man­age­ment with­out risk­ing expo­sure to the coro­n­avirus by vis­it­ing med­ical offices. Telemed­i­cine vis­its are typ­i­cal­ly con­duct­ed between a doc­tor and patient using video­con­fer­enc­ing or a phone call and are used to address minor ail­ments like colds as well as man­age­ment of chron­ic con­di­tions like dia­betes. [Read more…] about Debate: How and when will the telemed­i­cine surge reach men­tal health­care?

Startup Big Health raises $39M to universalize access to cognitive behavioral therapy (CBT) for anxiety and poor sleep

by Leave a Comment

Big Health Hones Dig­i­tal Men­tal Health Ther­a­py With $39M Series B (Crunch­base):

“Start­up Big Health believes indi­vid­u­als can improve their men­tal health through its tech­nol­o­gy that focus­es on cog­ni­tive behav­ioral ther­a­py ver­sus med­ica­tion or the help of human ther­a­pists.

On Thurs­day it raised $39 mil­lion in a Series B financ­ing to advance that objec­tive.

[Read more…] about Start­up Big Health rais­es $39M to uni­ver­sal­ize access to cog­ni­tive behav­ioral ther­a­py (CBT) for anx­i­ety and poor sleep

Four immediate priorities to flatten the mental distress curve

by Leave a Comment

The men­tal health cri­sis trig­gered by COVID-19 is esca­lat­ing rapid­ly. One exam­ple: When com­pared to a 2018 sur­vey, U.S. adults are now eight times more like­ly to meet the cri­te­ria for seri­ous men­tal dis­tress. One-third of Amer­i­cans report clin­i­cal­ly sig­nif­i­cant symp­toms of anx­i­ety or clin­i­cal depres­sion, accord­ing to a late May 2020 release of Cen­sus Bureau data.

While all pop­u­la­tion groups are affect­ed, this cri­sis is espe­cial­ly dif­fi­cult for stu­dents, par­tic­u­lar­ly those pushed off col­lege cam­pus­es and now fac­ing eco­nom­ic uncer­tain­ty; adults with chil­dren at home, strug­gling to jug­gle work and home-school­ing; and front-line health care work­ers, risk­ing their lives to save oth­ers. [Read more…] about Four imme­di­ate pri­or­i­ties to flat­ten the men­tal dis­tress curve

Three tips for wise minds to calm coronavirus anxiety

by Leave a Comment

__

In the ear­ly days of COVID-19, we faced many dif­fi­cult deci­sions in every­day life: try­ing to weigh risk and decide whether to meet up or stay home, send kids to school or vis­it the gym. Now that my home state of Cal­i­for­nia has its “shel­ter in place” order—and many oth­er cities and states are in var­i­ous stages of lockdown—a wait­ing peri­od has tak­en shape.

In some ways, this is a relief—our minds get deci­sion fatigue in the face of so many choic­es. Now we have our instruc­tions, which are restric­tive but use­ful to our brains. But many oth­er types of uncer­tain­ty still remain, about things like our jobs, whether we will get sick even while tak­ing pre­cau­tions, or when we will see our loved ones and return to some nor­mal rou­tines.

[Read more…] about Three tips for wise minds to calm coro­n­avirus anx­i­ety

The FDA clears Somryst, Pear’s digital therapeutic to treat chronic insomnia

by Leave a Comment

__

Pear gets FDA clear­ance for insom­nia ther­a­peu­tic (Med­C­i­ty News):

“Pear Ther­a­peu­tics received mar­ket­ing autho­riza­tion for its third prod­uct — a dig­i­tal ther­a­peu­tic intend­ed to treat chron­ic insom­nia. Called Som­ryst, the app is avail­able by pre­scrip­tion only. It con­sists of a nine-week pro­gram that includes cog­ni­tive behav­ioral ther­a­py and restrict­ing sleep to a lim­it­ed win­dow of time [Read more…] about The FDA clears Som­ryst, Pear’s dig­i­tal ther­a­peu­tic to treat chron­ic insom­nia

First Digital Health Formulary by Express Scripts includes CBT-based programs to treat depression, anxiety and insomnia

by Leave a Comment

Source: Express Scripts

_____

Express Scripts Launch­es First Dig­i­tal Health For­mu­la­ry for Apps & Devices (HIT Con­sul­tant):

“Start­ing in Jan­u­ary 2020, Express Scripts Dig­i­tal Health For­mu­la­ry will ini­tial­ly include 15 solu­tions for remote mon­i­tor­ing ser­vices and dig­i­tal ther­a­peu­tics that aid in the man­age­ment of eight of the country’s most com­mon chron­ic con­di­tions: dia­betes, pre­di­a­betes, hyper­ten­sion, asth­ma, pul­monary dis­ease, depres­sion, anx­i­ety, and insom­nia [Read more…] about First Dig­i­tal Health For­mu­la­ry by Express Scripts includes CBT-based pro­grams to treat depres­sion, anx­i­ety and insom­nia